📰 Contract Development News
Page 52 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
November 9, 2022
$40.8M of cash and cash equivalents at September 30, 2022 Discontinuation of fezagepras development Termination of legacy CDMO agreement for cash savings of...
November 9, 2022
$40.8M of cash and cash equivalents at September 30, 2022 Discontinuation of fezagepras development Termination of legacy CDMO agreement for cash savings of...
November 4, 2022
/PRNewswire/ -- Advanced BioScience Laboratories (ABL), a global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization...
November 3, 2022
/PRNewswire/ -- ReiThera, a biotech company dedicated to the development of new technologies, GMP production and the clinical translation of genetic vaccines...
November 3, 2022
- New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; - New facility will allow ReiThera
November 1, 2022
The "Global Bioprocess Validation Market (2022-2027) by Test Type, Process Component, End User, and Geography, Competitive Analysis and the Impact of Covid-19
October 31, 2022
Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka. The commercial production in the SML was started in November 1989. Today SML, with a consolidated revenue of R 1,159.76 crore for the year 2021-22 against the previous years’ revenue of Rs 931.27 crore, has emerged as a global brand within manufacturing and supplying of affordable API and Formulation globally in different regulated markets. The Group with over 20 subsidiaries is now...
October 31, 2022
A write up by- Mittur N. Jagadish, PhD Former Head of the Biotechnology Facilitation Cell, Department of IT BT and S&T, Government of Karnataka, Bengaluru, Karnataka, India. And President, IBioM (Indian Biotech and MSME Association)
October 31, 2022
New state-of-the-art manufacturing equipment and targeted debottlenecking would increase overall peptide and oligonucleotide capacity of the Frankfurt site to circa 500 kilograms per year by 2025
October 27, 2022
Investegate announcements from AGC Biologics, AGC Biologics Receives Excellence in Innovation and Leadership by Italys Leading Business News Channel Le Fonti